EDGAR Filing Documents for 0001104659-23-079156

Form 8-K - Current report:

SEC Accession No. 0001104659-23-079156

Filing Date

2023-07-07

Accepted

2023-07-07 16:34:50

Documents

Period of Report

2023-06-30

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2320799d1_8k.htm iXBRL	8-K	39386
2	EXHIBIT 10.1	tm2320799d1_ex10-1.htm	EX-10.1	49260
3	EXHIBIT 10.2	tm2320799d1_ex10-2.htm	EX-10.2	49311
4	EXHIBIT 10.3	tm2320799d1_ex10-3.htm	EX-10.3	59185
5	EXHIBIT 10.4	tm2320799d1_ex10-4.htm	EX-10.4	59736
9	GRAPHIC	tm2320799d1_ex10-3img001.jpg	GRAPHIC	4087
10	GRAPHIC	tm2320799d1_ex10-4img001.jpg	GRAPHIC	3996
	Complete submission text file	0001104659-23-079156.txt		507585

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	nbrv-20230630.xsd	EX-101.SCH	3012
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	nbrv-20230630_lab.xml	EX-101.LAB	34240
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	nbrv-20230630_pre.xml	EX-101.PRE	22357
12	EXTRACTED XBRL INSTANCE DOCUMENT	tm2320799d1_8k_htm.xml	XML	3473

Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034

Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640

Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)